Latest News


Dedicated to Discovery…Committed to Care


Leonard P. Zakim Center for Integrative Therapies and Healthy Living

Medical Director, Medical Oncologist


The Leonard. P. Zakim Center for Integrative Therapies and Healthy Living (Zakim Center) at Dana-Farber Cancer Institute is searching for the new Medical Director. This physician medical director will work directly with the overall director of the Center, other clinical leaders and clinicians across Dana-Farber, including solid tumor and hematologic malignancies groups, Survivorship, and Psychosocial Oncology and Palliative Care. The medical director will be expected to develop and implement initiatives to address the supportive care needs of cancer patients and survivors. The medical director will supervise the clinical providers in the Zakim Center and oversee Zakim Center clinical programs, including both in-person appointments and virtual group programming. In addition, the new medical director of the Zakim Center will see patients for Integrative Medicine Consultations 3-4 sessions per week, with the possibility of also providing clinical care and/or research in one of our disease-oriented or palliative care programs. Ideally, applicants should have a minimum of three years’ experience as a physician; experience working with patients with cancer is preferred. Strong clinical skills and an appreciation of evidence-based medicine are critical. In addition, they must have formal training or experience in integrative medicine and/or clinical nutrition or exercise. The successful candidate will also engage in educational programming for patients, staff, and faculty and will have the opportunity to participate in and/or lead clinical research projects focused on integrative therapies and lifestyle interventions in cancer patients and survivors. The chosen candidate will be teaching Harvard-trained fellows and students for a minimum of 50 hours per year. 

Appointment at the Instructor, Assistant or Associate Professor levels at Harvard Medical School will be commensurate to academic accomplishment. Salary and benefits will be competitive with other institutions. Candidates should have an MD or MD/PhD degree and must be board-certified or board-eligible in Internal Medicine and/or Medical Oncology.


Please send cover letter, curriculum vitae, names and email of three references to:


Jennifer Ligibel, MD

c/o Taylor Haggerty

Dana-Farber Cancer Institute, Department of Medical Oncology

450 Brookline Avenue, Suite YC1233

Boston, MA 02215

This email address is being protected from spambots. You need JavaScript enabled to view it.


We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability status, protected veteran status, pregnancy and pregnancy-related conditions or any other characteristic protected by law. Women and minority candidates are particularly encouraged to apply. 

Tribute to Barrie Cassileth, PhD 

Founding President of the Society for Integrative Oncology

A person with curly hairDescription automatically generated with low confidence

Founding Chief of the Memorial Sloan Kettering Cancer Center (MSK) Integrative Medicine Service (IMS) First Laurance S. Rockefeller Chair in Integrative Medicine.

Founding Member of the Advisory Council to the National Institute of Health’s Office of Alternative Medicine, now the National Center for Complementary and Integrative Health

Member, National and the NY–NJ Regional Boards of the American Cancer Society

It is with great sadness that we announce the passing of Dr. Barrie Cassileth, founding president of the Society for Integrative Oncology (SIO). “Dr. Cassileth was one of the most elegant, hardworking, and caring women I have ever met,” Ting Bao, MD, DABMA, MS, the director of Integrative Breast Oncology at MSK and Immediate Past-President of SIO, said of her mentor. “It is amazing how much the field of integrative medicine has developed over the past twenty years; this progress would have not been possible without her. We will all miss her greatly.”

From the beginning days of the Society in 2003, Dr. Cassileth sowed the seeds of research, education, international outreach, and the value of the patient voice, which grew into the thriving SIO of 2022. The Society is still prioritizing these goals as it leads the way towards comprehensive, evidence-informed, integrative oncology care to improve the lives of people with cancer worldwide.  

Dr. Cassileth was also the founding Chief of the Memorial Sloan Kettering Cancer Center (MSK) Integrative Medicine Service (IMS) and the first Laurance S. Rockefeller Chair in Integrative Medicine. “Dr. Cassileth had great courage and vision,” said Jun J. Mao, MD, MSCE, the current Chief of Integrative Medicine at MSK and SIO Past President, who also described how Dr. Cassileth’s seminal work in clinical programming and research opened doors for the field of evidence-informed integrative oncology.

Importantly, Dr. Cassileth oversaw the development of the first of a series of integrative oncology clinical practice guidelines, which continue to be developed today by SIO in collaboration with mainstream organizations such as the American Society for Clinical Oncology (ASCO). As Dr. Cassileth explained in a 2017 ASCO Post interview, “My strong belief in the necessity of helping patients and family members, as well as physicians and staff, participate in cancer research spurred me on. It was always clear that patients and family members need more than excellent surgery, chemotherapy, radiation, and all the new treatments.”

Born in Philadelphia, Dr. Cassileth attended Bennington College in Vermont, which she described as “a cauldron of intellectual freedom.” She earned a PhD in medical sociology at the University of Pennsylvania while working in the UPenn Comprehensive Cancer Center’s inpatient unit for people with leukemia, where she was deeply affected by her interaction with patients who were in the end-stages of the disease. It was at UPenn that she also initiated the first palliative care program that included psychosocial therapies in an academic setting in the US.  

After a period of years in North Carolina, where she was appointed Consulting Professor of Community and Family Medicine at Duke, she was recruited in 1999 by Memorial Sloan Kettering Cancer Center (MSK) in New York City to develop an integrative medicine program. This program, the Integrative Medicine Service at MSK, still offers complementary therapies to inpatients at the main MSK hospital as well as outpatient services and is still conducting practice-changing research in integrative oncology. 

It was partly the need for scientifically robust clinical research supporting the use of complementary therapies to manage symptoms and side effects of cancer and its treatment that inspired Dr. Cassileth to found the Society for Integrative Oncology in 2003. She invited like-minded pioneers in research who were also committed to improving the lives of people with cancer. These fellow integrative medicine research pioneers became the founding members of SIO and its first presidents, David Rosenthal, MD; Debu Tripathy, MD; Peter Johnstone, MD; and Lorenzo Cohen, PhD.  

During her long career, Dr. Cassileth published several books, from The Alternative Medicine Handbook: The Complete Reference Guide to Alternative and Complementary Therapies in 1998 to The Complete Guide to Complementary Therapies in Cancer Care in 2011, and, in 2014, Survivorship: Living Well During and After Cancer. 

Next year, SIO will celebrate its Twentieth Anniversary at the 20th International Conference in Banff, Alberta. Today, as we carry forward the mission of SIO, we gratefully offer this tribute to Dr. Barrie Cassileth, the kind, brilliant, and visionary founding president of the Society for Integrative Oncology.


29-30 Jan and 12-13 Feb 2022

Designed for anyone who is affected by cancer, Your Life and Cancer 2022 aims to introduce you to the growing world of Integrative Medicine, combining lifestyle, complementary and conventional approaches.

Held over two weekends 29-30 Jan and 12-13 Feb 2022, Your Life and Cancer features doctors, oncologists, therapists, best-selling authors and case studies from people who have benefited from taking an integrative approach.

More than 40 cancer care experts from around the world will be online to share their knowledge and expertise and provide you with tools to improve health and vitality, help manage side effects, build resilience, manage stress & anxiety and reduce the risk of recurrence.

Register for just £40 per weekend:

SIO Members can register using a discount code. To access the discount code, please log in using your SIO log in credentials.

Find out more:

SIO leaders have co-authored a defining international publication alongside key stakeholders from NIH, WHO, Europe, and countries such as Brazil, Argentina, and India. Titled "Integrative oncology: Addressing the global challenges of cancer prevention and treatment", the open-access article was published in CA: A Cancer Journal for Clinicians. Corresponding author and SIO Past-President, Jun J. Mao, MD, MSCE, Chief of Integrative Medicine Service at Memorial Sloan Kettering Cancer Center writes, "We advocate for using SIO's integrative oncology framework to further develop this field to meet the global challenges of cancer control." This publication builds on the momentum of global collaboration demonstrated at the September 2021 SIO 18th International Conference, during which oncology leaders from countries around the world discussed priorities for improving oncology outcomes worldwide.

 Find the link to the article here


Transdisciplinary (TD) Training Opportunity in Energetics and Cancer!

We are in our 6th year of building a diverse community of transdisciplinary (TD) and translational (TL) researchers including those interested in cancer disparities and invite you to apply to our mentored program: The Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop.

The Workshop builds upon the NCI TREC Initiative and covers topics across the cancer control and T 0 -T 4 continua.

Funded by the U.S. National Cancer Institute and led by Yale University’s Dr. Melinda Irwin with a Senior Advisory Board and expert international faculty, this program builds capacity in TD and TL energetics and cancer research and is designed for early career investigators (i.e., junior faculty and postdocs). This 5-day, in  residence* Workshop places emphasis on developing and applying TD and TL competencies focused on energetics (i.e., obesity, diet and exercise) and cancer. Faculty span an array of professional disciplines, from basic scientists to clinicians to behavioral and population scientists. Formal didactic learning is integrated with one-on-one dialog and small group discussions to enable fellows to learn from each other, from faculty, and to develop a TD and TL network.

Below are a few of many testimonials as voiced by our previous cohorts.

The 6 th annual course will be held June 19-24, 2022 at Water’s Edge Resort, Westbrook, CT, U.S.A.*
Costs will be covered. 

Notification of Intent to apply (simple, informal email to This email address is being protected from spambots. You need JavaScript enabled to view it.) is due no later than December 15, 2021. Full application is due no later than Friday, January 14, 2022.

For more detail and to apply, visit  Questions: contact Diana Lowry This email address is being protected from spambots. You need JavaScript enabled to view it.

*Travel contingent on safety allowances due to the COVID-19 pandemic. If necessary, we will conduct the 2022 Workshop virtually via Zoom, June 19-24, 2022. Decision will be made by April 1, 2022.

***** Testimonials ********

This was an amazing experience and completely unique. (Fellow)

This workshop reaffirmed my commitment to energy balance and cancer research. Connecting with experts in the field and gaining their input into developing ideas was critical. (Fellow)

This training and networking was awesome! There was clearly a cumulative effect of 6 days together. (Fellow)

The caliber of trainees and faculty is amazing. What a treat to be able to interact with this group. (Faculty)

A meeting unlike any other. Many opportunities for networking and collaboration. Highly recommend! (Fellow)

The TREC Workshop was incredibly helpful. I learned about grant writing, transdisciplinary research, and gained more knowledge in the field in one week than I could have in one year. It was a wonderful opportunity to meet experts in energy balance who are there to educate and mentor young investigators. I’ve kept in touch with a few of the faculty and co-fellows, and I hope to keep these relationships for years to come. (Fellow)

Caliber of faculty & fellows = amazing week of high-quality science, networking, career advice, collaboration! (Fellow)

High bar to meet going forward! Kudos all around! (Faculty)

The networking and collaborative opportunities at this meeting are unmatched! (Fellow)

The TREC Workshop was phenomenal. The opportunity to be in a small group setting with such important thought leaders in the field of energy balance was unique and invaluable. The curriculum was well-thought out and balanced, covering all components of this transdisciplinary field. There was also plenty of time for informal networking and brainstorming. (Fellow)

August 6, 2021

Dr. Jun Mao, SIO Past President and current SIO Trustee, comments on cancer patients who have struggled with addiction in the past and how it affects their pain management.

Listen to Dr. Jun Mao on Good Morning America here, and where Kathy Griffin opens up about her treatment after lung cancer surgery.

Mission Statement 

The Society for Integrative Oncology (SIO) affirms the dignity, equality, and equity of all people. We recognize that all are not treated with respect, and we commit ourselves to working for justice, equity, diversity, inclusion, and belonging among both internal and external stakeholders. With this in mind, SIO and the SIO Health Equity, Inclusion & Belonging Task Force (HEI&B TF) commit to the following core values:

  • Uphold the inherent equality of persons of every race, ethnicity, sex, gender, sexual orientation, religion, ability, location, nationality, socioeconomic experience, and any other difference through respectful and kind interaction.
  • Acknowledge that modern integrative oncology therapies have their roots in the health traditions of indigenous peoples of many nations, cultures, and ethnicities through the use of appropriate images, wording, and actions in all SIO activities and events.
  • Practice inclusivity and belonging by inviting and welcoming members from underrepresented communities by supporting inclusion and belonging and identifying and eliminating barriers to participation.
  • Create a system to continuously educate ourselves about cancer health inequities, their etiology, and how to dismantle the structural and systemic factors that sustain them. This includes exploring and monitoring our own biases and privileges.

The HEI&B TF supports the SIO in being an inclusive, just, and diverse organization that promotes equity and belonging by taking the following actions:

  • Assessing the makeup of SIO leadership and membership through demographic surveys.
  • Promoting inclusion by identifying inequities within the SIO, including power inequities, and recommending changes to counter these inequities.
  • Identifying justice, equity, diversity, and inclusion training and other resources for SIO members and requiring that Board members participate in such training.
  • Conducting annual reviews of the SIO’s entity reports, surveys, and other assessments deemed appropriate.
  • Developing and implementing a mechanism for SIO members to safely bring concerns about aggressions and microaggressions experienced within the Society.
  • Supporting the SIO in creating a safe and compassionate space to work for justice, equity, diversity, inclusion, and belonging.

We also acknowledge the fluidity of our understanding and commit to adapting our language and actions to our intentions as we continue to learn. We recognize that the language of health equity continues to evolve over time as our society processes current and past events. 


Land Acknowledgment Statement 

The following land acknowledgement statement will be used at SIO events, both in-person and virtual, that are taking place on lands where there has been a history of colonialization. SIO members are also encouraged to acknowledge the land on which they are situated in their activities with the Society. 

The Society of Integrative Oncology acknowledges that the land where many of us live is often the traditional and ancestral territory of Indigenous/Aboriginal/First Nations peoples.  We acknowledge the harm done to these peoples and communities through genocide, the violation of treaties, and other systemic discriminatory policies. We commit to honoring the unique cultural heritages, healing traditions, and values of these communities as we pursue our mission to improve the lives of people with cancer through evidence-informed, equitable, and person-centered integrative cancer care.

                                   LogoDescription automatically generated

Gateway for Cancer Research and Society for Integrative Oncology join forces 

CHICAGO, IL (June 23, 2021) Gateway for Cancer ResearchSM, a non-profit organization dedicated to funding transformational cancer research, announces a scientific collaboration with the Society for Integrative Oncology™ (SIO) to advance evidence-based integrative research.  

This new initiative has been established to identify compelling areas of inquiry in the field of integrative cancer research and to fund the talented clinician-scientists best positioned to pursue these studies. A direct path for SIO members has been established to ease the process of applying for a grant opportunity. 

“Gateway for Cancer Research and SIO share an urgent commitment to discovering integrative strategies that will make a real difference for those facing cancer,” said Michael Burton, president and CEO, Gateway for Cancer Research. “We are proud to partner with SIO to establish this promising grant program, and we are confident that our collaboration will significantly contribute to and accelerate progress for the patients we serve.”

“We are excited to collaborate with Gateway for Cancer Research to create a pathway for new integrative oncology research,” said Dr. Ting Bao, President of SIO. “This joint effort aligns perfectly with SIO’s mission to support scientifically robust research on evidence-informed integrative therapies to improve the lives of people affected by cancer and marks an important step forward in the field of integrative oncology.”

For more information on Gateway for Cancer Research please visit us at or contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information on the Society for Integrative Oncology, please visit our website at or contact us at This email address is being protected from spambots. You need JavaScript enabled to view it..

To submit an LOI, please visit the Grants Management portal at SIO Integrative Program

About Gateway for Cancer Research℠ 

Gateway for Cancer ResearchSM is a nonprofit 501c(3) organization committed to funding innovative cancer research that helps people living with cancer to feel better and live longer as we work to end cancer as we know it. Thanks to generous underwriting, 99 cents of every dollar Gateway receives directly funds Phase I and Phase II cancer clinical trials at leading research institutions across the country and abroad. Since 1991, Gateway has supported more than 190 clinical trials and funded over $90 million in breakthrough cancer research, serving over 9,000 patients. Get involved today by visiting, like us on Facebook at and join the conversation on Twitter at @GatewayforCR and Instagram at @GatewayforCR, #BeAGateway

About Society for Integrative Oncology™

Founded in 2003, SIO is the premier multi-disciplinary professional organization for integrative oncology. A 501(c)(3) not-for-profit organization, SIO enables communication, education, and research to occur by bringing together practitioners from multiple disciplines focused on the care of cancer patients and survivors. Follow SIO on LinkedIn, Facebook and YouTube (@Society for Integrative Oncology), Twitter and Instagram (@integrativeonc). #integrativeonc

wellness wednesday logo 2020

SIO Wellness Wednesdays Series 2021

SIO is thrilled to announce our popular Wellness Wednesday series will return this summer with two webinars per month from June through August. Each Wellness Wednesday will include a free, live, one-hour informal lunch conversation with cancer subject matter experts who will illuminate the challenges faced by people touched by cancer, particularly those in underrepresented communities. Our goal is to highlight the benefits of integrative medicine in the context of equitable cancer care.

Click here for information on Episode One. 

Click here for information on Episode Two.

Click here for information on Episode Three.

Click here for information on Episode Four.

Click here for information on Episode Five.

Click here for information on Episode Six.

SIO Wellness Wednesdays Series 2020

SIO Wellness Wednesdays Series Available on YouTube

In case you missed our 2020 summer series #WellnessWednesdays - or, if you want to watch an episode again, visit SIO's YouTube channel to access recordings and the meditations and yoga practices.

Oncology Peer Review On-The-Go: Recommending Patient-Reported Outcomes of Pain for Cancer Care

In this episode of "Oncology Peer Review On-The-Go", CancerNetwork takes a look at an article publishing in early 2021 for the Journal ONCOLOGY, titled “Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations.”

The piece summarizes current and validated patient-reported outcomes (PROs) specific to cancer-related pain. The piece also recommends commonly used PROs to be standardized to aid integrative oncology clinicians and researchers in both patient care and study design. For the first of 2 interviews regarding this piece, CancerNetwork spoke with 3 authors of the article, W. Iris Zhi, MD, PhD, and Ting Bao, MD, DABMA, MS, from the Memorial Sloan Kettering Cancer Center, and Xin Shelley Wang, MD, MPH, of the MD Anderson Cancer Center.

For the response perspective, CancerNetwork spoke with Linda Carlson, PhD, of the Cumming School of Medicine at the University of Calgary. Carlson expanded on the work done by Zhi and her colleagues, emphasizing the importance of understanding reliability and validity. Carlson focused on the importance of the research topic, and the impact properly validated PROs can have on patients for the cancer care team.